Suzanne Nielsen (S Nielsen)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 77

Top Topics

Systematic Review

General Practice

Top Venues

Drug and alcohol review

Addiction (Abingdon, England)

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna C Moullin, Lexy Staniland, Hannah Uren, Suzanne Nielsen, Simon Lenton
Advancing the implementation of take-home naloxone by community pharmacists: Testing the role of COM-B. Drug and alcohol review (2024)
Helena Cangadis-Douglass, Ting Xia, J Simon Bell, Suzanne Nielsen
Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data. British journal of clinical pharmacology (2024)
Ting Xia, Louisa Picco, Rachelle Buchbinder, Romi Haas, Suzanne Nielsen
Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia. British journal of clinical pharmacology 90 (4) (2024)
Joanna C Moullin, Lexy Staniland, Hannah Uren, Suzanne Nielsen, Simon Lenton
Advancing the implementation of take-home naloxone by community pharmacists: Testing the role of COM-B. Drug and alcohol review 43 (3) (2024)
Jessie Maher, Jacqui McCoy, Raimondo Bruno, Suzanne Nielsen
The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study. International journal of clinical pharmacy (2024)
Elizabeth Grist, Ali Cheetham, John Jackson, Penelope Wood, Sarah Lord, Angelo Pricolo, Ferghal Armstrong, Kirsty Morgan, Catherine Nguyen, Tom Tran, Suzanne Nielsen
Clinical effectiveness of pharmacist administration of long-acting injectable buprenorphine: Findings from the EPIC-MATOD study. Drug and alcohol review (2024)
Rose Laing, Ting Xia, Elizabeth Grist, Jana Dostal, Suzanne Nielsen, Louisa Picco
Correlates of stocking naloxone: a cross-sectional survey of community pharmacists. International journal of clinical pharmacy (2024)
Ting Xia, Louisa Picco, Rachelle Buchbinder, Romi Haas, Suzanne Nielsen
Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia. British journal of clinical pharmacology (2024)
Nandini Karthikeyan, Ting Xia, Suzanne Nielsen, Louisa Picco
Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia. Drug and alcohol review (2024)
Nandini Karthikeyan, Ting Xia, Suzanne Nielsen, Louisa Picco
Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia. Drug and alcohol review 43 (5) (2024)
Elizabeth Ann Sturgiss, Jenny Advocat, Christopher A Barton, Emma N Walker, Suzanne Nielsen, Annemarie Wright, Tina Lam, Nilakshi Gunatillaka, Symrin Oad, Christopher Wood
Using Text Messaging Surveys in General Practice Research to Engage With People From Low-Income Groups: Multi-Methods Study. JMIR mHealth and uHealth 12 (2024)
Elizabeth Ann Sturgiss, Jenny Advocat, Christopher A Barton, Emma N Walker, Suzanne Nielsen, Annemarie Wright, Tina Lam, Nilakshi Gunatillaka, Symrin Oad, Christopher Wood
Using Text Messaging Surveys in General Practice Research to Engage With People From Low-Income Groups: Multi-Methods Study. JMIR mHealth and uHealth 12 (2024)
Joanna C Moullin, Lexy Staniland, Hannah Uren, Suzanne Nielsen, Simon Lenton
Advancing the implementation of take-home naloxone by community pharmacists: Testing the role of COM-B. Drug and alcohol review 43 (3) (2024)
Ting Xia, Louisa Picco, Rachelle Buchbinder, Romi Haas, Suzanne Nielsen
Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia. British journal of clinical pharmacology 90 (4) (2024)
E Michell, Tina Lam, T Xia, Suzanne Nielsen, Jennifer A Stevens
The relationship between presurgical opioid type and persistent postoperative opioid use: a retrospective observational linkage study comparing tapentadol and oxycodone. Anaesthesia (2023)
Suzanne Nielsen, Rachelle Buchbinder, Christopher M Pearce, Dan Lubman, Samanta Lalic, Romi Haas, Louisa Picco, Monica Jung, Helena Cangadis-Douglass, Jenni Ilomaki, J Simon Bell, Ting Xia
Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia. BMJ open 13 (5) (2023)
Louisa Picco, Alison Ritter, Suzanne Nielsen
Prescription drug monitoring programs in Australia: A call for a comprehensive evaluation. Drug and alcohol review (2023)
Elizabeth Ann Sturgiss, Jenny Advocat, Tina Lam, Suzanne Nielsen, Lauren E Ball, Nilakshi Gunatillaka, Catherine Martin, Christopher A Barton, Chun Wah Michael Tam, Helen Skouteris, Danielle Mazza, Grant M Russell
Multifaceted intervention to increase the delivery of alcohol brief interventions in primary care: a mixed-methods process analysis. The British journal of general practice : the journal of the Royal College of General Practitioners (2023)
Sarah Larney, Nicola R Jones, Matthew Hickman, Suzanne Nielsen, Robert Ali, Louisa Degenhardt
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17. Addiction (Abingdon, England) (2023)
Amelia Berg, Leanne Francia, Tina Lam, Kirsty Morgan, Dan I Lubman, Suzanne Nielsen
Enriching qualitative alcohol and other drug research by engaging lived experience peer researchers in a dual-interview approach: A case study. Drug and alcohol review (2023)
Yonas Getaye Tefera, Shannon Elise Gray, Suzanne Nielsen, Asmare Yitayeh Gelaw, Alex Collie
Impact of Prescription Medicines on Work-Related Outcomes in Workers with Musculoskeletal Disorders or Injuries: A Systematic Scoping Review. Journal of occupational rehabilitation (2023)
Louisa Picco, Ting Xia, J Simon Bell, Christopher Pearce, Rachelle Buchbinder, Dan I Lubman, Suzanne Nielsen
Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis. Drug and alcohol review (2023)
Sarah Haines, Michael Savic, Suzanne Nielsen, Adrian Carter
Opioid-related policy changes: Experiences and perspectives from people who use opioids to manage non-cancer chronic pain. Drug and alcohol review (2023)
Louisa Picco, Monica Jung, Helena Cangadis-Douglass, Tina Lam, Suzanne Nielsen
Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs' Algorithms and Clinical Screening Tools. Pharmacy (Basel, Switzerland) 11 (5) (2023)
Ting Xia, Louisa Picco, Samanta Lalic, Rachelle Buchbinder, J Simon Bell, Nadine E Andrew, Daniel I Lubman, Christopher M Pearce, Suzanne Nielsen
Determining the Impact of Opioid Policy on Substance Use and Mental Health-Related Harms: Protocol for a Data Linkage Study. JMIR research protocols 12 (2023)
Amy Gray McNeilage, Suzanne Nielsen, Bridin Murnion, Claire Elizabeth Ashton-James
Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review protocol. BMJ open 13 (9) (2023)
Suzanne Nielsen, Rachelle Buchbinder, Christopher M Pearce, Dan Lubman, Samanta Lalic, Romi Haas, Louisa Picco, Monica Jung, Helena Cangadis-Douglass, Jenni Ilomaki, J Simon Bell, Ting Xia
Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia. BMJ open 13 (5) (2023)
Aili Veronica Langford, Christine Cw Lin, Lisa Bero, Fiona M Blyth, Jason Doctor, Simon Holliday, Yun-Hee Jeon, Joanna Moullin, Bridin Murnion, Suzanne Nielsen, Rawa Osman, Jonathan Penm, Emily Reeve, Sharon Reid, Janet Wale, Carl R Schneider, Danijela Gnjidic
Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. The Medical journal of Australia (2023)
Suzanne Nielsen, Rachelle Buchbinder, Christopher M Pearce, Dan Lubman, Samanta Lalic, Romi Haas, Louisa Picco, Monica Jung, Helena Cangadis-Douglass, Jenni Ilomaki, J Simon Bell, Ting Xia
Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia. BMJ open 13 (5) (2023)
Tina Lam, Sarah Callinan, Suzanne Nielsen, Freya Horn, Leanne Francia, Brian Vandenberg
Which alcohol products might be affected by the introduction of a minimum unit price in Western Australia? Findings from a survey of alcohol retail prices. Drug and alcohol review (2023)
Sarah Larney, Nicola R Jones, Matthew Hickman, Suzanne Nielsen, Robert Ali, Louisa Degenhardt
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-2017. Addiction (Abingdon, England) (2023)
Suzanne Nielsen, Rachelle Buchbinder, Christopher M Pearce, Dan Lubman, Samanta Lalic, Romi Haas, Louisa Picco, Monica Jung, Helena Cangadis-Douglass, Jenni Ilomaki, J Simon Bell, Ting Xia
Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia. BMJ open 13 (5) (2023)
Suzanne Nielsen, Rachelle Buchbinder, Christopher M Pearce, Dan Lubman, Samanta Lalic, Romi Haas, Louisa Picco, Monica Jung, Helena Cangadis-Douglass, Jenni Ilomaki, J Simon Bell, Ting Xia
Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia. BMJ open 13 (5) (2023)
Lauren Ann Monds, Maria Bravo, Llewellyn Mills, Annie Malcolm, Rosie Gilliver, William Wood, Mary Ellen Harrod, Phillip Read, Suzanne Nielsen, Paul M Dietze, Simon Lenton, Anne M Bleeker, Nicholas Lintzeris
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions. Drug and alcohol review 41 (5) (2022)
Tina Lam, Nicholas Biggs, Ting Xia, John Evans, Jennifer Stevens, Mike da Gama, Dan I Lubman, Suzanne Nielsen
Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia. BMJ open 12 (4) (2022)
Louisa Picco, Tina Lam, Ting Xia, Suzanne Nielsen
Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists. International journal of clinical pharmacy (2022)
Monica Jung, Helena Cangadis-Douglass, Suzanne Nielsen, Samanta Lalic, Malcolm Dobbin, Grant Russell, Pallavi Prathivadi, Pene Wood, Elizabeth Manias, Cik Y Lee, Carolyn Arnold, Megan Kuleas, Jennifer L Schumann, Jenni Ilomäki, J Simon Bell
What are the research priorities for optimising the safe and effective use of opioids in Australian general practice? Drug and alcohol review (2022)
Tina Lam, Monica J Barratt, Mark Bartlett, Julie Latimer, Marianne Jauncey, Sarah Hiley, Nico Clark, Dimitri Gerostamoulos, Linda Glowacki, Claude Roux, Marie Morelato, Suzanne Nielsen
Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia. Addiction (Abingdon, England) 117 (8) (2022)
Louisa Picco, Tina Lam, Ting Xia, Suzanne Nielsen
Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists. International journal of clinical pharmacy (2022)
Suzanne Nielsen, Sarah Larney
Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment? Addiction (Abingdon, England) 118 (1) (2022)
Emma Zahra, Rory Chen, Suzanne Nielsen, Anh Dam Tran, Thomas Santo, Louisa Degenhardt, Michael Farrell, Jude Byrne, Robert Ali, Briony Larance
Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients. Drug and alcohol review 41 (4) (2022)
Chris Tremonti, Suzanne Nielsen
The emerging issue of Kamini: A new source of opioid dependence. Drug and alcohol review (2022)
Monica Jung, Dickson Lukose, Suzanne Nielsen, J Simon Bell, Geoffrey I Webb, Jenni S Ilomaki
COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia - a nationwide study. British journal of clinical pharmacology (2022)
Leanne Francia, Tina Lam, Amelia Berg, Kirsty Morgan, Michael Savic, Dan I Lubman, Suzanne Nielsen
Putting out the welcome mat-A qualitative exploration of service delivery processes and procedures as barriers to treatment-seeking for people who use alcohol and other drugs. Drug and alcohol review (2022)
Malcolm Dobbin, Suzanne Nielsen, Jennifer L Schumann
Commentary on McCoy et al. (2021): More pieces of the mosaic describing outcomes of the Australian up-scheduling of over-the-counter codeine to prescription only. Addiction (Abingdon, England) (2021)
Suzanne Nielsen, Nick Scott, Tom Tidhar, Maria Del Mar Quiroga, Simon Lenton, Paul Dietze
The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid-related deaths: findings from a modelling study. Addiction (Abingdon, England) (2021)
Suzanne Nielsen, Paul G Sanfilippo, Debbie Scott, Tina Lam, Karen Smith, Daniel I Lubman
Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018. Addiction (Abingdon, England) 116 (8) (2021)
Suzanne Nielsen, Natasa Gisev, Janni Leung, Philip James Clare, Raimondo Bruno, Nicholas Lintzeris, Briony Larance, Fiona Blyth, Wayne Hall, Milton Cohen, Louisa Degenhardt, Michael Farrell, Gabrielle Campbell
Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study. British journal of clinical pharmacology 87 (8) (2021)
Jacqui McCoy, Suzanne Nielsen, Raimondo Bruno
A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine. Addiction (Abingdon, England) (2021)
Tina Lam, Jane Hayman, Janneke Berecki-Gisolf, Paul G Sanfilippo, Daniel I Lubman, Suzanne Nielsen
Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids. Addiction (Abingdon, England) (2021)
Suzanne Nielsen, Rose Crossin, Melissa Middleton, Tina Lam, James Wilson, Debbie Scott, Catherine Martin, Karen Smith, Daniel I Lubman
Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018. Addiction (Abingdon, England) 115 (6) (2020)
Tina Lam, Jane Hayman, Janneke Berecki-Gisolf, Paul Sanfilippo, Dan I Lubman, Suzanne Nielsen
Comparing rates and characteristics of emergency department presentations related to pharmaceutical opioid poisoning in Australia: a study protocol for a retrospective observational study. BMJ open 10 (9) (2020)
James Wilson, Tina Lam, Debbie Scott, Rose Crossin, Sharon Matthews, Karen Smith, Dan I Lubman, Suzanne Nielsen
'Extreme personal stress' and 'a lot of pain': Exploring the physical, mental and social contexts of extramedical pharmaceutical opioid use in Australian paramedic case descriptions. Drug and alcohol review 39 (7) (2020)
Briony Larance, Marianne Byrne, Nicholas Lintzeris, Suzanne Nielsen, Jason Grebely, Louisa Degenhardt, Jeyran Shahbazi, Marian Shanahan, Kari Lancaster, Gregory Dore, Robert Ali, Michael Farrell, null null
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study. BMJ open 10 (7) (2020)
Suzanne Nielsen, Paul Sanfilippo, Louisa Picco, Raimondo Bruno, Michala Kowalski, Pene Wood, Sarah Larney
What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy. International journal of clinical pharmacy 43 (2) (2020)
Banafsheh Moradmand-Badie, Lucy Tran, Noora Oikarainen, Louisa Degenhardt, Suzanne Nielsen, Jillian Roberts, Stephen Ward, Julia Bowman, Sarah Larney
Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia. Drug and alcohol review 40 (1) (2020)
Suzanne Nielsen, Paul Sanfilippo, Vendula Belackova, Carolyn A Day, Edmund Silins, Nicholas Lintzeris, Raimondo Bruno, Jason Grebely, Kari Lancaster, Robert Ali, James Bell, Paul Dietze, Louisa Degenhardt, Michael Farrell, Briony Larance
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction (Abingdon, England) 116 (6) (2020)
Shalini Arunogiri, Suzanne Nielsen
Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence? Drug and alcohol review 39 (3) (2020)
Suzanne Nielsen, Andrew McAuley
Etizolam: A rapid review on pharmacology, non-medical use and harms. Drug and alcohol review 39 (4) (2020)
Jacqui McCoy, Suzanne Nielsen, Raimondo Bruno
Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study. JMIR research protocols 9 (3) (2020)
Briony Larance, Louisa Degenhardt, Jason Grebely, Suzanne Nielsen, Raimondo Bruno, Paul M Dietze, Kari Lancaster, Sarah Larney, Thomas Santo, Marian Shanahan, Sonja Memedovic, Robert L Ali, Michael Farrell
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction (Abingdon, England) 115 (7) (2020)
Thomas Santo, Briony Larance, Raimondo Bruno, Natasa Gisev, Suzanne Nielsen, Louisa Degenhardt, Gabrielle Campbell
Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain. Drug and alcohol review 39 (2) (2019)
Nicholas Lintzeris, Lauren A Monds, Maria Bravo, Phillip Read, Mary E Harrod, Rosie Gilliver, William Wood, Suzanne Nielsen, Paul M Dietze, Simon Lenton, Marian Shanahan, Marianne Jauncey, Meryem Jefferies, Susan Hazelwood, Adrian J Dunlop, Martina Greenaway, Paul Haber, Nadine Ezard, Annie Malcom
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives. Drug and alcohol review 39 (1) (2019)
Tina Lam, Lisa Kuhn, Jane Hayman, Melissa Middleton, James Wilson, Debbie Scott, Daniel I Lubman, Karen Smith, Suzanne Nielsen
Recent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018. Addiction (Abingdon, England) 115 (2) (2019)
Suzanne Nielsen, Sarah Larney, Michael Farrell
Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world. Addiction (Abingdon, England) 113 (3) (2019)
Suzanne Nielsen
Commentary on Cairns et al. (2020): Codeine rescheduling-where to from here? Addiction (Abingdon, England) 115 (3) (2019)
Gabrielle Campbell, Emily A Stockings, Suzanne Nielsen
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European archives of psychiatry and clinical neuroscience 269 (1) (2019)
Suzanne Nielsen, Kari Lancaster
Commentary on Chang et al. (2018): Assessing prescribing volume and patient risk-implementation considerations. Addiction (Abingdon, England) 113 (4) (2019)
Suzanne Nielsen, Bridin Murnion, Gabrielle Campbell, Helen Young, Wayne Hall
Cannabinoids for the treatment of spasticity. Developmental medicine and child neurology 61 (6) (2019)
Shann Hulme, Caitlin Elizabeth Hughes, Suzanne Nielsen
What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non-medical use between 2010 and 2016. Drug and alcohol review 38 (4) (2019)
Suzanne Nielsen, Rose Crossin, Melissa Middleton, Catherine Martin, James Wilson, Tina Lam, Debbie Scott, Karen Smith, Dan Lubman
Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study. BMJ open 9 (5) (2019)
Suzanne Nielsen, Paul M Dietze
What can Australia learn from the North American opioid crisis? The role of opioid regulation and other evidence-based responses. Drug and alcohol review 38 (3) (2019)
Suzanne Nielsen, Nicholas Lintzeris, Bridin Murnion, Louisa Degenhardt, Raimondo Bruno, Paul Haber, Jennifer Johnson, Mark Hardy, Stephen Ling, Craig Saddler, Adrian Dunlop, Apo Demirkol, Catherine Silsbury, Nghi Phung, Jennie Houseman, Briony Larance
Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence. Drug and alcohol review 37 (7) (2018)
Monica J Barratt, Julie Latimer, Marianne Jauncey, Emma My Tay, Suzanne Nielsen
Urine drug screening for early detection of unwitting use of fentanyl and its analogues among people who inject heroin in Sydney, Australia. Drug and alcohol review 37 (7) (2018)
Suzanne Nielsen, Rada Germanos, Megan Weier, John Pollard, Louisa Degenhardt, Wayne Hall, Nicholas Buckley, Michael Farrell
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. Current neurology and neuroscience reports 18 (2) (2018)
Jacqui McCoy, Raimondo Bruno, Suzanne Nielsen
Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication. Drug and alcohol review 37 (2) (2017)
Suzanne Nielsen, Pamela Sabioni, Jose M Trigo, Mark A Ware, Brigid D Betz-Stablein, Bridin Murnion, Nicholas Lintzeris, Kok Eng Khor, Michael Farrell, Andrew Smith, Bernard Le Foll
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 42 (9) (2017)